heteronemin and Carcinoma

heteronemin has been researched along with Carcinoma* in 1 studies

Other Studies

1 other study(ies) available for heteronemin and Carcinoma

ArticleYear
Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells.
    Marine drugs, 2020, Jul-02, Volume: 18, Issue:7

    Heteronemin, a marine sesterterpenoid-type natural product, possesses an antiproliferative effect in cancer cells. In addition, heteronemin has been shown to inhibit. We investigated the antiproliferative effects by Cell Counting Kit-8 and flow cytometry. The signal transduction pathway was measured by Western blotting analyses. Quantitative PCR was used to evaluate gene expression regulated by heteronemin, 3,3',5,5'-tetraiodothyroacetic acid (tetrac), or their combined treatment in oral cancer cells.. Both heteronemin and tetrac inhibited ERK1/2 activation and increased p53 phosphorylation. They also inhibited

    Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gingival Neoplasms; Humans; Terpenes; Thyroxine

2020